 | • レポートコード：MRC2305C126 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、233ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、世界の研究用抗体＆試薬市場規模が2021年に124.3億ドル、2022年に139.2億ドルとなり、更に年平均12.03％成長して2027年には245.9億ドルに達すると予測しています。当市場調査レポートでは、研究用抗体＆試薬の世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別分析（抗体、試薬）、技術別分析（酵素免疫測定法、フローサイトメトリー、免疫蛍光、免疫組織化学、免疫沈降）、疾患別分析（免疫疾患、感染症、神経生物学、腫瘍、幹細胞）、用途別分析（医薬品開発、ゲノミクス、プロテオミクス）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。なお、当書には、Abcam plc、Agilent Technologies, Inc.、Analytik Jena AG、Atlas Antibodies、Becton, Dickinson and Company、Bio-Rad Laboratories, Inc.、BioLegend, Inc.、Cell Signaling Technology, Inc.、Danaher Corporation、Dovetail Genomics LLC、F. Hoffmann-La Roche AGなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の研究用抗体＆試薬市場規模：製品別 - 抗体の市場規模 - 試薬の市場規模 ・世界の研究用抗体＆試薬市場規模：技術別 - 酵素免疫測定法の市場規模 - フローサイトメトリーの市場規模 - 免疫蛍光の市場規模 - 免疫組織化学の市場規模 - 免疫沈降の市場規模 ・世界の研究用抗体＆試薬市場規模：疾患別 - 免疫疾患における市場規模 - 感染症における市場規模 - 神経生物学における市場規模 - 腫瘍における市場規模 - 幹細胞における市場規模 ・世界の研究用抗体＆試薬市場規模：用途別 - 医薬品開発における市場規模 - ゲノミクスにおける市場規模 - プロテオミクスにおける市場規模 ・世界の研究用抗体＆試薬市場規模：地域別 - 南北アメリカの研究用抗体＆試薬市場規模 アメリカの研究用抗体＆試薬市場規模 カナダの研究用抗体＆試薬市場規模 ブラジルの研究用抗体＆試薬市場規模 ... - アジア太平洋の研究用抗体＆試薬市場規模 日本の研究用抗体＆試薬市場規模 中国の研究用抗体＆試薬市場規模 インドの研究用抗体＆試薬市場規模 韓国の研究用抗体＆試薬市場規模 台湾の研究用抗体＆試薬市場規模 ... - ヨーロッパ/中東/アフリカの研究用抗体＆試薬市場規模 イギリスの研究用抗体＆試薬市場規模 ドイツの研究用抗体＆試薬市場規模 フランスの研究用抗体＆試薬市場規模 ロシアの研究用抗体＆試薬市場規模 ... - その他地域の研究用抗体＆試薬市場規模 ・競争状況 ・企業情報 |
The Global Research Antibodies & Reagents Market size was estimated at USD 12.43 billion in 2021 and expected to reach USD 13.92 billion in 2022, and is projected to grow at a CAGR 12.03% to reach USD 24.59 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Research Antibodies & Reagents to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Antibodies and Reagent. The Antibodies is further studied across Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Antibodies. The Reagent is further studied across Buffers, Enzymes, Fixatives, Media & Sera, Probes, Solvents, and Stains & Dyes.
Based on Technology, the market was studied across Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence, Immunohistochemistry, Immunoprecipitation, and Western Blotting.
Based on Indication, the market was studied across Immunology, Infectious Diseases, Neurobiology, Oncology, and Stem Cells.
Based on Application, the market was studied across Drug Development, Genomics, and Proteomics.
Based on End User, the market was studied across Academic & Research Institutions, Contract Research Organizations, and Pharmaceutical & Biotechnology.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Research Antibodies & Reagents market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Research Antibodies & Reagents Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Research Antibodies & Reagents Market, including Abcam plc, Agilent Technologies, Inc., Analytik Jena AG, Atlas Antibodies, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioLegend, Inc., Cell Signaling Technology, Inc., Danaher Corporation, Dovetail Genomics LLC, F. Hoffmann-La Roche AG, GE Healthcare, Genscript Biotech Corp., Illumia, Inc., ImmunoPrecise Antibodies Ltd., Johnson & Johnson, Lonza Group AG, Merck KGaA, Omega Bio-tek, Inc., PerkinElmer, Inc., Santa Cruz Biotechnology, Inc., and Thermo Fisher Scientific, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Research Antibodies & Reagents Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Research Antibodies & Reagents Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Research Antibodies & Reagents Market?
4. What is the competitive strategic window for opportunities in the Global Research Antibodies & Reagents Market?
5. What are the technology trends and regulatory frameworks in the Global Research Antibodies & Reagents Market?
6. What is the market share of the leading vendors in the Global Research Antibodies & Reagents Market?
7. What modes and strategic moves are considered suitable for entering the Global Research Antibodies & Reagents Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growth in stem cell and neurobiology research
5.1.1.2. Increasing focus on biomarker discovery globally
5.1.1.3. Growth in proteomics and genomics research
5.1.2. Restraints
5.1.2.1. Quality concerns and lack of reproducible results
5.1.3. Opportunities
5.1.3.1. Increasing research activity and funding for R&D in research antibodies & reagents
5.1.3.2. Increasing trend personalized medicine and protein therapeutics
5.1.4. Challenges
5.1.4.1. Cost and time-intensive antibody development processes
5.2. Cumulative Impact of COVID-19
6. Research Antibodies & Reagents Market, by Product
6.1. Introduction
6.2. Antibodies
6.3.1. Monoclonal Antibodies
6.3.2. Polyclonal Antibodies
6.3.3. Recombinant Antibodies
6.3. Reagent
6.4.1. Buffers
6.4.2. Enzymes
6.4.3. Fixatives
6.4.4. Media & Sera
6.4.5. Probes
6.4.6. Solvents
6.4.7. Stains & Dyes
7. Research Antibodies & Reagents Market, by Technology
7.1. Introduction
7.2. Enzyme-linked Immunosorbent Assay
7.3. Flow Cytometry
7.4. Immunofluorescence
7.5. Immunohistochemistry
7.6. Immunoprecipitation
7.7. Western Blotting
8. Research Antibodies & Reagents Market, by Indication
8.1. Introduction
8.2. Immunology
8.3. Infectious Diseases
8.4. Neurobiology
8.5. Oncology
8.6. Stem Cells
9. Research Antibodies & Reagents Market, by Application
9.1. Introduction
9.2. Drug Development
9.3. Genomics
9.4. Proteomics
10. Research Antibodies & Reagents Market, by End User
10.1. Introduction
10.2. Academic & Research Institutions
10.3. Contract Research Organizations
10.4. Pharmaceutical & Biotechnology
11. Americas Research Antibodies & Reagents Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Research Antibodies & Reagents Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Research Antibodies & Reagents Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Abcam plc
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Agilent Technologies, Inc.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Analytik Jena AG
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Atlas Antibodies
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Becton, Dickinson and Company
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Bio-Rad Laboratories, Inc.
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. BioLegend, Inc.
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Cell Signaling Technology, Inc.
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Danaher Corporation
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Dovetail Genomics LLC
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. F. Hoffmann-La Roche AG
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. GE Healthcare
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Genscript Biotech Corp.
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Illumia, Inc.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. ImmunoPrecise Antibodies Ltd.
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Johnson & Johnson
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Lonza Group AG
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Merck KGaA
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Omega Bio-tek, Inc.
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. PerkinElmer, Inc.
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
15.21. Santa Cruz Biotechnology, Inc.
15.21.1. Business Overview
15.21.2. Key Executives
15.21.3. Product & Services
15.22. Thermo Fisher Scientific, Inc.
15.22.1. Business Overview
15.22.2. Key Executives
15.22.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing